2025-09-28 - Analysis Report
Okay, here's an analysis of Salesforce Inc. (CRM) based on the provided data, formatted for a clear and concise report:

## Salesforce Inc. (CRM) Analysis

**Company Overview:** Salesforce Inc. is a global leader in cloud-based software, providing customer relationship management (CRM) services.

### 1. Performance vs. S&P 500 (VOO)

*   **Cumulative Return (CRM):** -15.51%
*   **Cumulative Return (VOO):** 66.41%
*   **Disparity:** -69.0%
*   **Relative Disparity:** 1.4

**Analysis:** CRM has significantly underperformed the S&P 500. The large negative disparity and low relative disparity indicate that CRM's performance is currently near its historical low compared to the S&P 500 within the given timeframe.

### 1.1 Alpha/Beta Analysis

| Year       | CAGR    | MDD   | Alpha  | Beta  | Cap(B) |
| ---------- | ------- | ----- | ------ | ----- | ------ |
| 2015-2017  | 30.0%   | 69.9% | 21.0%  | 0.0   | 97.3   |
| 2016-2018  | 34.0%   | 71.1% | 35.0%  | -0.1  | 130.4  |
| 2017-2019  | 22.0%   | 72.0% | 18.0%  | 0.1   | 154.8  |
| 2018-2020  | 20.0%   | 72.0% | -5.0%  | 0.1   | 211.8  |
| 2019-2021  | 42.0%   | 72.0% | 14.0%  | 0.4   | 241.9  |
| 2020-2022  | -73.0%  | 74.7% | -88.0% | 0.3   | 126.2  |
| 2021-2023  | -43.0%  | 76.7% | -61.0% | -0.6  | 250.5  |
| 2022-2024  | -50.0%  | 76.7% | -63.0% | -0.3  | 318.3  |
| 2023-2025  | -5.0%   | 76.7% | -40.0% | -1.9  | 231.8  |

**Analysis:**

*   **CAGR:** CRM's Compound Annual Growth Rate has varied significantly, with negative values in recent periods.
*   **MDD:** Maximum Drawdown is consistently high, indicating substantial risk.
*   **Alpha:** Alpha is largely negative in recent years, suggesting underperformance relative to its benchmark.
*   **Beta:** Beta has fluctuated, turning negative recently, implying a potentially inverse correlation with the market.
*   **Cap(B):** Market capitalization generally increased over time.

### 2. Recent Stock Price Fluctuations

*   **Current Price:** 243.43
*   **Previous Close:** 240.95
*   **Change:** 1.03 (Slight positive movement)
*   **5-day Moving Average:** 245.08
*   **20-day Moving Average:** 246.87
*   **60-day Moving Average:** 251.99

**Analysis:** The price is below all three moving averages, suggesting a short-term downtrend. The recent small price increase may indicate a potential short-term rebound, but this needs to be confirmed with further price action.

### 3. Market Risk Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 39.68 (Approaching oversold territory)
*   **PPO:** -0.0124
*   **Hybrid Signal:** Buy 100% of cash (4 shares - Very Safe - MRI:0.90), Monthly invest 0.8% of total investment ($1,000.00)
*   **Recent (20-day) Relative Disparity Change:** 1.4 (+) Short-term increase.
*   **Expected Return:** -2053.2%

**Analysis:**

*   The MRI suggests a favorable investment environment, which seems contradictory given other indicators.
*   The RSI is below 40, approaching the oversold level, indicating a potential buying opportunity if a reversal is confirmed.
* PPO is showing a downtrend
*   The Hybrid Signal recommends buying and investing a small portion monthly, indicating a cautious approach.
*   The recent positive change in relative disparity suggests potential short-term upward momentum.
*   **The expected return is exceptionally negative, which is highly unusual and warrants further investigation of the underlying model or data.**

### 4. Recent News & Significant Events

*   **Insider Selling:** Multiple reports of insider selling.
*   **Investment in UK:** Salesforce plans to invest $6 billion in the UK by 2030.
*   **AI Data Wars:** Commentary on the future of AI and data.

**Analysis:** Insider selling can sometimes be a negative signal, but it needs to be considered in context with the overall picture. The investment in the UK is a positive long-term indicator. The AI data wars article indicates the need for monitoring competitive risks and opportunities.

### 4.2 Analyst Opinions

*   **Consensus:** Buy (~1.60)
*   **Target Price (avg/high/low):** 334.87 / 430.00 / 221.00

**Analysis:** The analyst consensus is a buy, with a significant upside based on the average target price. However, the low target price suggests some analysts are less optimistic. The lack of recent rating changes suggests stability in analyst opinions.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출      |
| ---------- | ----- | --------- |
| 2025-09-04 | 1.97  | 10.24 B$  |
| 2025-05-29 | 1.61  | 9.83 B$   |
| 2024-12-04 | 1.6   | 9.44 B$   |
| 2024-08-29 | 1.48  | 9.32 B$   |
| 2025-09-04 | 1.48  | 9.32 B$   |

**Analysis:**

*   Both EPS and Revenue show an upward trend over the last few quarters.
*   The most recent EPS and Revenue figures are the highest in the analyzed period, suggesting positive growth momentum.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
| ---------- | --------- | ------------- |
| 2025-07-31 | $10.24B  | 78.10%        |
| 2025-04-30 | $9.83B   | 76.96%        |
| 2025-01-31 | $9.99B   | 77.81%        |
| 2024-10-31 | $9.44B   | 77.71%        |
| 2024-07-31 | $9.32B   | 76.85%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE      |
| ---------- | --------- | -------- |
| 2025-07-31 | $61.33B  | 3.08%    |
| 2025-04-30 | $60.67B  | 2.54%    |
| 2025-01-31 | $61.17B  | 2.79%    |
| 2024-10-31 | $58.52B  | 2.61%    |
| 2024-07-31 | $57.63B  | 2.48%    |

**Analysis:**

*   **Revenue:** Revenue has been steadily increasing, indicating healthy top-line growth.
*   **Profit Margin:** Profit margins are consistently high, showcasing efficient operations.
*   **Equity:** Equity has been increasing, reflecting a strengthening balance sheet.
*   **ROE:** Return on Equity is positive and has increased recently, indicating improved profitability.

### 7. Overall Summary and Considerations

Salesforce (CRM) presents a mixed picture.

**Positive Points:**

*   **Strong Fundamentals:** Growing revenue, high-profit margins, and increasing equity indicate a fundamentally sound company.
*   **Analyst Consensus:** Analysts generally rate the stock as a "Buy" with a significant upside potential.
*   **Growth Initiatives:** The planned investment in the UK demonstrates long-term growth ambitions.
*    **Recent News:** Investment in UK, Revenue and EPS is on the rise.

**Negative Points:**

*   **Underperformance:** Significant underperformance compared to the S&P 500, as reflected by the cumulative return disparity and negative alpha.
*   **Downtrend:** The stock price is below its moving averages, signaling a short-term downtrend.
*   **Insider Selling:** Recent insider selling could be a cause for concern.
*    **Expected Return:** The expected return is exceptionally negative, which is highly unusual and warrants further investigation of the underlying model or data.

**Recommendations:**

*   **Due Diligence:** Investigate the exceptionally negative expected return and the reasons for the recent underperformance.
*   **Monitor Price Action:** Closely monitor the stock's price action for signs of a reversal.
*   **Consider a Cautious Approach:** Given the mixed signals, a cautious investment approach might be warranted, potentially using a dollar-cost averaging strategy.
*   **Evaluate Insider Selling:** Determine the context and reasons behind the insider selling activity.

